The law of 29 December 2011 regarding the upscaling of drug and health product safety guarantees the independence and impartiality of healthcare decisions.
It requires transparent relationships between the healthcare industry and other players in the field of healthcare, healthcare professionals, students, learned societies, associations, media, etc.
A relationship of interest does not entail a conflict of interests. To develop their products, companies have to build relationships with experts, journalists and public figures. It is, of course, necessary to preserve and develop this complementarity, which brings science forward and allows for therapeutic progress.
At the same time, it is necessary for these relationships to be publicly known and easily accessible.
By revealing the existence of these relationships, the “Healthcare Transparency” public database allows each internet user to objectively consider the nature of relationships between the healthcare industries with other key players in the sector.
All data regarding the transparency of relationships between healthcare professionals and Bioprojet Société Civile de Recherche [Civil Research Company] are available below:
The data from 2013 onwards are available on the dedicated site: https://www.transparence.sante.gouv.fr/
n compliance with the law of “Information and Liberties” of 6 January 1978 and subsequent amendments and decree n° 2005-1309 of 20 October 2005, you have the right to access and rectify information concerning you.
You can exercise this right with bioprojet Société Civile de Recherche by e-mailing email@example.com or by post to 9 rue Rameau – 75002 PARIS.